All stock reports

INNOVANA evidence report

Evidence date: 2026-10-01. Research observations only.

What can I do with this stock?

Evaluated 2026-10-02T01:37:53.224812+00:00. Closed-session evidence: 2026-10-01. This is a timestamped assessment, not a live trading feed.

Strategy evidence, instrument feasibility and portfolio suitability are separate. Portfolio suitability has not been assessed.

Today: intraday

Evidence unavailable

No current intraday signal and observed quote supplied; daily bars cannot establish a live setup.

  • No current intraday signal and observed quote supplied; daily bars cannot establish a live setup.

Next week: five trading sessions

No qualifying opportunity

No candidate with a primary five-session horizon in the coherent source run.

  • No candidate with a primary five-session horizon in the coherent source run.

Long term: one to three years

Research only

A financial screen alone does not establish an investment recommendation.

  • Financial data quality flags require resolution.
  • A current, source-backed thesis and valuation review is required.

Investment evidence

Statement coverage
FULL_STATEMENTS
Financial source retrieved
2026-09-11T23:40:15.839306+00:00

Metrics

latest_annual_period
2026-03-31
revenue
1323074000.0
net_income
381433000.0
operating_cash_flow
322619000.0
free_cash_flow
254772000.0
total_assets
3650090000.0
total_liabilities
856726000.0
total_equity
2724458000.0
cash
112686000.0
total_debt
579197000.0
revenue_growth
0.2785831423941121
earnings_growth
-0.13586223926887675
net_margin
0.2882930206473712
roe
0.1400032593638808
debt_to_equity
0.2125916420807368
cash_conversion
0.8458077827560804
free_cash_flow_margin
0.19256065798284902
trailing_pe
Not supplied
forward_pe
Not supplied
peg_ratio
Not supplied
price_to_book
Not supplied
dividend_yield
Not supplied

Other positional research

Research only

1 opportunity assessments; compare evidence and conditions below.

Price Dislocation

Research only. Direction: LONG.

Flags large price dislocations for research without asserting unsupported fundamental quality

  • No active, unexpired validation authority for this exact strategy and horizon.
  • A source-backed entry, invalidation, exit and cost plan is not supplied.
Eligible expression
None selected
Expression comparison
No eligible instrument selected.
Invalidation
Continued price deterioration or adverse fundamental evidence
Entry rule
Not supplied
Entry range (INR)
Not supplied
Exit / review rule
Not supplied
Planned exit
Not supplied
Plan valid until
Not supplied
Promotion reference
Not supplied
Instrument scenarios in INR; quantities are illustrative, not personal sizing
InstrumentEvidence statusContractQuantityCapital / marginTarget P&L after costsStop-level scenario P&LStress lossConditions and limitations
NO_POSITIONAvailableNot suppliedNot suppliedNot supplied0.000.00Not suppliedNo new position; incremental trading P&L is zero.
CASHUnavailableNot suppliedNot suppliedNot suppliedNot suppliedNot suppliedNot suppliedObserved contract, quote and cost evidence not supplied.
FUTURESUnavailableNot suppliedNot suppliedNot suppliedNot suppliedNot suppliedNot suppliedObserved contract, quote and cost evidence not supplied.
OPTIONSUnavailableNot suppliedNot suppliedNot suppliedNot suppliedNot suppliedNot suppliedObserved contract, quote and cost evidence not supplied.
  • No reader capital or loss budget supplied
Decision provenance and limitations
Decision ID
decision-694e9fc3a4993130029b2cf83bb3627beb31f481961d4cbf5c22b9cd417f7d9d
Policy
stock-decisions-v1
Evidence bundle hash
04118372e58c3faf75d0712fad9daa9a5b38969187bad7471e595ab83c83b38a
  • market-brief: a7de4d64fedac164d48cdfb9b4081a4666d7f797f7d9c58da304b329b3a61d3c
  • validation-registry: b1069587129bfc64a703cdf8322d0294692585b7d67f5472593e4164bbb0c3bc
  • financial-statements: 9b131fb407f36b3ba53e080d9e07467f2d292168994f80f3fcc9829df3649e1d
  • daily-price: 6b66fdb1e9436e62b45872ea3c6beb8e6db87505c5d1c5e9057262fec8d8130a
  • Conditional research decisions are not orders or personalized position sizes.
  • Scenario payoffs are assumptions, not probabilities or expected returns.
  • A stop price does not guarantee a maximum loss through a gap or illiquidity.

Download the decision evidence as JSON

Evidence briefing

The local language model selected and grouped the following supplied facts.

Overview

Price source verification: REPAIRED. The trailing 250-session price return was -40.47%. The cached financial metric revenue growth is 0.2785831423941121. The cached financial metric net margin is 0.2882930206473712.

Risks

The closing price was -42.89% below its highest close in the available trailing year. Financial data check: balance_sheet_equation: difference=68906000.00. Historical observations do not establish future returns. No verified current news or catalyst evidence is supplied.

Follow Up

Average cached traded value over twenty sessions was INR 11,384,486. The cached financial metric roe is 0.1400032593638808. The cached financial metric debt to equity is 0.2125916420807368. The cached financial metric cash conversion is 0.8458077827560804. The cached financial metric free cash flow margin is 0.19256065798284902.

Cached observations and evidence limits